Funding

Switzerland Based Polares Medical Raises $50M Funding In Series C Round

Mar 5, 2026 | By Kailee Rainse

Polares Medical, a clinical-stage structural heart company based in Lausanne, Switzerland, has raised $50 million in a Series C funding round.

SUMMARY

Polares Medical, a clinical-stage structural heart company based in Lausanne, Switzerland, has raised $50 million in a Series C funding round.

The round was backed by DC Global Ventures, Lumination Partners, existing investors, and a new strategic investor.

The company will use the proceeds to expand operations and advance its research and development activities.

RECOMMENDED FOR YOU

Funding

London-based Spaceflux Raises £9 Million To Expand Space Intelligence Globally

Oliver Bennett

May 1, 2026

Funding

FIRE1 funding news – Dublin-based FIRE1 has Raised $120M in Funding

Kailee Rainse

Jan 7, 2025

Acquisition

Podimo acquisition news – Copenhagen-based Podimo has acquired Podads

Oliver Bennett

Oct 3, 2024

Led by CEO Jacques R. Essinger, Polares Medical is developing the MRace Posterior Leaflet Replacement system, a transcatheter therapy designed to treat patients with mitral regurgitation.

“We believe Posterior Leaflet Replacement represents a new chapter in transcatheter mitral therapy,” said Jacques R. Essinger, Ph.D., Chief Executive Officer of Polares Medical. “With over 70 patients of clinical experience and encouraging one-year data demonstrating sustained safety and efficacy, we have established a strong foundation for MRace. This financing positions us to advance the treatment paradigm for complex mitral regurgitation.”

About Polares Medical

Polares Medical SA is a clinical-stage structural heart company developing the MRace Posterior Leaflet Replacement system, a novel transcatheter therapy designed to treat patients suffering from mitral regurgitation.